Pareteum soars on cryptocurrency billing

Pareteum adds Blockchain settlement for cryptocurrency to platform

Cryptocurrency mania continues as the bitcoin bubble expands

Pareteum-Corp soars on cryptocurrency billing - Stockwinners.com
Pareteum soars on cryptocurrency billing

Pareteum Corp. (TEUM) announced that it has completed development enabling it to add support of Blockchain technology to its billing and settlement services.

“This newest service capability enables Pareteum customers to participate in the transformational ‘Digital Economy Monetization to the Cloud’ and now accept and process Bitcoin, Ethereum, Litecoin, Airtokens and other forms of cryptocurrencies,” said the company, whose share were halted pending the news release.

Hal Turner, Executive Chairman and Principal Executive Officer of Pareteum, added:

“We envision a time in the not too distant future when Pareteum could create its own currency payments and settlements among the millions of subscribers on its platform globally.

As we consider the new global mobile landscape, and Pareteum’s service and capabilities developments in 2017, which have opened doors for us in the Internet of Things, Smart Cities, and use of Artificial Intelligence and Machine Learning creating predictive analytics for the vast amounts of digital data we are capable of securely processing, we maintain an optimistic view towards 2018 and beyond.”

CRYPTO TREND

Cryptocurrency revenues have been pointed to as reasons to be bullish on Advanced Micro Devices (AMD) and Nvidia (NVDA) in select research. Overstock (OSTK), Digital Power (DPW), Long Blockchain (LTEA), Seven Stars Cloud Group (SSC), Riot Blockchain (RIOT), Longfin (LFIN) and Social Reality (SRAX) are other stocks that have been touted, or promoted themselves, as a way to play the crypto theme.

Pareteum (TEUM) jumps 99% to $2.54 after adding blockchain technology.


STOCKWINNERS

To read timely stories similar to this, along with money making trade ideas, sign up for a membership to Stockwinners

This article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility.

Boston Omaha jumps on Buffett connection

Boston Omaha rises after WSJ profile highlights link to Buffett

Stockwinners offers real time news and information
Boston Omaha jumps on Buffett connection

Shares of billboard advertisement seller and surety insurer Boston Omaha (BOMN) are rising following a Friday profile of the company in the Wall Street Journal.

SHARES DOUBLE SINCE LISTING

Shares of Boston Omaha, which is run by co-CEOs Alex Buffet Rozek and Adam Peterson, have more than doubled since listing on the Nasdaq Stock Market in June.

The company, which recently reported third quarter revenue of $2.4M, has a market capitalization of over $447M with today’s advance.

Rozek, who is Warren Buffett’s grandnephew, said the company receives no assistance from Buffett or Berkshire Hathaway (BRK.A, BRK.B) and does not advertise the link as he wants Boston Omaha’s results to stand on their own.

boston omaha shares jump on Buffett connection. Stockwinners.com
Boston Omaha shares jump on Buffett connection.

“It’s not like there’s this private class that goes on for family members about business,” Rozek said.

“If I wanted to learn, the best thing I could do is pick up an annual report and read the Berkshire annual report like anybody else.”

Buffett, who doesn’t own Boston Omaha stock, said, “I think the world of Alex, but we don’t have anything to do with his decision-making or anything of the sort. He’s got a good mind, a very good mind, and he certainly has good values.”

Boston Omaha, however has shown some similarities to Berkshire, including an acquisition focus on companies with consistent earnings and strong competitive positions, running acquired companies independently and skipping earning calls for an annual meeting.

The company, which does not currently invest in stocks, is 55% owned by Peterson’s Magnolia Group and 12% owned by Rozek’s Boulderado Group and other entities he manages.

PRICE ACTION

Boston Omaha is up 20.1%, or $5.69, to $34.02 in Tuesday’s trading. Including Friday’s advance, the stock is up over 33% over the last two sessions.


STOCKWINNERS

To read timely stories similar to this, along with money making trade ideas, sign up for a membership to Stockwinners

This article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility.

Hubbell to acquire Aclara Technologies for $1.1B

Hubbell to acquire Aclara Technologies for $1.1B

Hubbell to acquire Aclara Technologies for $1.1B. Stockwinners.com
Hubbell to acquire Aclara Technologies for $1.1B

Hubbell (HUBB) announced that it has entered into a definitive agreement to acquire Aclara Technologies, an affiliate of Sun Capital Partners for approximately $1.1B in an all- cash transaction.

Hubbell Incorporated designs, manufactures, and sells electrical and electronic products in the United States and internationally.

The transaction strengthens and broadens Hubbell Power Systems’ competitive position across utility markets.

The acquisition will combine the complementary strengths of Aclara and Hubbell Power Systems, providing the opportunity to integrate Aclara’s strong customer relationships and smart infrastructure solutions into the Hubbell portfolio and accelerate ongoing innovation efforts to address utility customer demand for data and integrated solutions.

Aclara offers a comprehensive suite of solutions, including advanced metering infrastructure, meters and edge devices, software, and installation services.

Aclara reported revenues of $500M and adjusted EBITDA of $90M for the fiscal year ended September 30, 2017.

The transaction is expected to be accretive in 2018 to Hubbell’s diluted EPS, excluding intangible amortization and deal related costs, and in 2019 on a GAAP basis.

Further, Hubbell expects to maintain an investment grade rating. Hubbell has obtained fully committed bridge financing from J.P. Morgan Securities, BofA Merrill Lynch, and HSBC Securities.

Hubbell expects its debt-to-adjusted EBITD ratio to be 3.1x at the close of the transaction, and anticipates reducing this ratio over the next few years.

The transaction, which is expected to be completed in 1Q18, is subject to the satisfaction of customary closing conditions, including U.S. antitrust clearance.

HUBB closed at $135.23.


STOCKWINNERS

To read timely stories similar to this, along with money making trade ideas, sign up for a membership to Stockwinners

This article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility.

Apple lower on soft iPhone X demand

Apple slides as Taiwanese report raises fears about iPhone X

Stocks to Buy, Stocks to Buy on Margin, Stocks to invest in, stocks to own
Apple lower on weak iPhone X demand

Apple (AAPL) shares are weaker as U.S. investors return from the long holiday weekend after a Taiwanese newspaper report said the tech giant is trimming its first-quarter sales forecast, according to Bloomberg.

Adding to the caution are analysts following suit, reportedly due to worries about demand for the high-end iPhone X.

ANALYSTS, APPLE SAID TO TRIM FORECASTS

Taiwanese newspaper Economic Daily News quoted unidentified supply chain officials as having said that Apple is lowering its first-quarter iPhone sales forecast to 30 million units from 50 million, according to Bloomberg.

It also said Hon Hai Precision Industry Co.’s main iPhone X manufacturing hub in Zhengzhou, China, stopped recruiting workers. The company also known as Foxconn is the sole iPhone X assembler, and also makes the handsets in Shenzhen and Chengdu.

An Apple representative declined to comment on production decisions, the report noted.

Additionally, Bloomberg noted that analysts at New York-based JL Warren Capital and China’s Sinolink Securities have each lowered iPhone X shipment projections for the first quarter of next year.

Apple has been counting on a redesigned 10th anniversary iPhone to boost shipments as its market value advances toward $1 trillion. The Cupertino, California-based company is facing new challenges from Samsung Electronics Co., which is quickly recovering from the Galaxy Note 7’s recall after fires. In the meantime, Chinese brands such as Huawei, Oppo and Xiaomi are also luring away potential customers in China and other emerging markets such as India.

SUPPLIERS TO WATCH

Suppliers to Apple that may be volatile following Bloomberg’s cautious report regarding signs of slack iPhone X demand include Skyworks (SWKS), Cirrus Logic (CRUS), Broadcom (AVGO), Qorvo (QRVO), Qualcomm (QCOM), STMicroelectronics (STM), Analog Devices (ADI), Knowles (KN) and Micron (MU).

PRICE ACTION

In pre-market trading, Apple shares are down $4.73, or 2.7%, to $170.28.


STOCKWINNERS

To read timely stories similar to this, along with money making trade ideas, sign up for a membership to Stockwinners

This article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility.

Sucampo Pharmaceutical sold for $1.2 billion

Mallinckrodt to acquire Sucampo for $18.00 per share  

Sucampo Pharma sold for $1.2B. Stockwinners
Sucampo Pharma sold for $1.2B

Mallinckrodt (MNK) and Sucampo Pharmaceutical (SCMP) announced that they have entered into an agreement under which Mallinckrodt will acquire Sucampo, including its commercial and development assets.

The transaction was approved by the Boards of Directors of both companies. Sun Acquisition, a subsidiary of Mallinckrodt, will commence a cash tender offer to purchase all of the outstanding shares of Sucampo Pharmaceuticals’ common stock for $18.00 per share.

The total transaction value is approximately $1.2B.

The acquisition is expected to be funded through borrowings under Mallinckrodt’s existing revolving credit facility, a new secured term loan facility and/or cash on hand.

Following the transaction, Mallinckrodt intends to utilize its significant cash generation to focus on reducing outstanding debt over time.

Sucampo stockholders holding approximately 32% of the outstanding Sucampo shares have entered into a tender and support agreement for this transaction.

Mallinckrodt expects accretion from the acquisition to adjusted diluted earnings per share of at least 30c in 2018 and at least double that amount in 2019, assuming a first quarter 2018 close.

Guidance on the impact of the acquisition to the company’s GAAP 35c diluted earnings per share has not been provided due to the inherent difficulty of forecasting the timing or amount of items that would be included in calculating such impact.

The transaction is subject to customary closing conditions, including expiration of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act, and the tender of a majority of the outstanding Sucampo shares.

MNK closed at $23.32. SCMP closed at $17.00.


STOCKWINNERS

To read timely stories similar to this, along with money making trade ideas, sign up for a membership to Stockwinners

This article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility.